BECTON DICKINSON AND CO (1BDX.MI) Stock Fundamental Analysis
BIT:1BDX - Euronext Milan - US0758871091 - Common Stock - Currency: EUR
Overall 1BDX gets a fundamental rating of 4 out of 10. We evaluated 1BDX against 57 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1BDX while its profitability can be described as average. 1BDX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
1BDX had positive earnings in the past year.
In the past year 1BDX had a positive cash flow from operations.
1BDX had positive earnings in each of the past 5 years.
In the past 5 years 1BDX always reported a positive cash flow from operatings.
1.2 Ratios
1BDX has a Return On Assets (2.79%) which is in line with its industry peers.
1BDX has a Return On Equity (6.02%) which is in line with its industry peers.
The Return On Invested Capital of 1BDX (5.16%) is comparable to the rest of the industry.
1BDX had an Average Return On Invested Capital over the past 3 years of 5.27%. This is below the industry average of 8.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.79% | ||
| ROE | 6.02% | ||
| ROIC | 5.16% |
ROA(3y)2.96%
ROA(5y)2.8%
ROE(3y)6.26%
ROE(5y)6.09%
ROIC(3y)5.27%
ROIC(5y)4.6%
1.3 Margins
1BDX has a Profit Margin of 7.28%. This is comparable to the rest of the industry: 1BDX outperforms 59.65% of its industry peers.
In the last couple of years the Profit Margin of 1BDX has grown nicely.
The Operating Margin of 1BDX (13.06%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of 1BDX has grown nicely.
1BDX's Gross Margin of 44.64% is on the low side compared to the rest of the industry. 1BDX is outperformed by 63.16% of its industry peers.
In the last couple of years the Gross Margin of 1BDX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.06% | ||
| PM (TTM) | 7.28% | ||
| GM | 44.64% |
OM growth 3Y5.79%
OM growth 5Y2.6%
PM growth 3Y-6.88%
PM growth 5Y6.19%
GM growth 3Y0%
GM growth 5Y-1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BDX is destroying value.
The number of shares outstanding for 1BDX has been reduced compared to 1 year ago.
1BDX has more shares outstanding than it did 5 years ago.
1BDX has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.04 indicates that 1BDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
1BDX's Altman-Z score of 2.04 is in line compared to the rest of the industry. 1BDX outperforms 50.88% of its industry peers.
The Debt to FCF ratio of 1BDX is 7.44, which is on the high side as it means it would take 1BDX, 7.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.44, 1BDX is in line with its industry, outperforming 52.63% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that 1BDX is somewhat dependend on debt financing.
1BDX has a Debt to Equity ratio of 0.70. This is in the lower half of the industry: 1BDX underperforms 71.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 7.44 | ||
| Altman-Z | 2.04 |
ROIC/WACC0.72
WACC7.12%
2.3 Liquidity
1BDX has a Current Ratio of 1.13. This is a normal value and indicates that 1BDX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.13, 1BDX is not doing good in the industry: 71.93% of the companies in the same industry are doing better.
A Quick Ratio of 0.64 indicates that 1BDX may have some problems paying its short term obligations.
With a Quick ratio value of 0.64, 1BDX is not doing good in the industry: 82.46% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.21% over the past year.
The Earnings Per Share has been growing slightly by 2.41% on average over the past years.
Looking at the last year, 1BDX shows a small growth in Revenue. The Revenue has grown by 5.84% in the last year.
The Revenue has been growing slightly by 3.14% on average over the past years.
EPS 1Y (TTM)15.21%
EPS 3Y0.23%
EPS 5Y2.41%
EPS Q2Q%5.68%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y1.79%
Revenue growth 5Y3.14%
Sales Q2Q%4.5%
3.2 Future
1BDX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.08% yearly.
Based on estimates for the next years, 1BDX will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y8.85%
EPS Next 2Y6.03%
EPS Next 3Y6.35%
EPS Next 5Y6.08%
Revenue Next Year8.24%
Revenue Next 2Y6.53%
Revenue Next 3Y5.94%
Revenue Next 5Y5.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
1BDX is valuated correctly with a Price/Earnings ratio of 12.67.
Based on the Price/Earnings ratio, 1BDX is valued cheaper than 91.23% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. 1BDX is valued rather cheaply when compared to this.
1BDX is valuated correctly with a Price/Forward Earnings ratio of 12.06.
84.21% of the companies in the same industry are more expensive than 1BDX, based on the Price/Forward Earnings ratio.
1BDX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.67 | ||
| Fwd PE | 12.06 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BDX indicates a somewhat cheap valuation: 1BDX is cheaper than 71.93% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1BDX is valued cheaper than 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.74 | ||
| EV/EBITDA | 13.68 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.43
PEG (5Y)5.25
EPS Next 2Y6.03%
EPS Next 3Y6.35%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.30%, 1BDX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.34, 1BDX pays a better dividend. On top of this 1BDX pays more dividend than 84.21% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, 1BDX has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
5.2 History
The dividend of 1BDX has a limited annual growth rate of 0.75%.
Dividend Growth(5Y)0.75%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1BDX pays out 75.71% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1BDX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP75.71%
EPS Next 2Y6.03%
EPS Next 3Y6.35%
BIT:1BDX (7/10/2025, 7:00:00 PM)
153.2
+7.4 (+5.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners92.78%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner ChangeN/A
Market Cap43.91B
Analysts74.29
Price Target183.9 (20.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
Yearly Dividend3.26
Dividend Growth(5Y)0.75%
DP75.71%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)1.1%
Max EPS beat(2)14.05%
EPS beat(4)4
Avg EPS beat(4)5%
Min EPS beat(4)0.11%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)4.46%
EPS beat(12)10
Avg EPS beat(12)4.47%
EPS beat(16)14
Avg EPS beat(16)6.3%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-2.51%
Max Revenue beat(2)0.37%
Revenue beat(4)2
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-2.67%
Max Revenue beat(4)0.37%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)6
Avg Revenue beat(12)-0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.49%
PT rev (1m)-6.93%
PT rev (3m)N/A
EPS NQ rev (1m)-0.51%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.01%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.67 | ||
| Fwd PE | 12.06 | ||
| P/S | 2.45 | ||
| P/FCF | 19.74 | ||
| P/OCF | 15.5 | ||
| P/B | 2.03 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.68 |
EPS(TTM)12.09
EY7.89%
EPS(NY)12.7
Fwd EY8.29%
FCF(TTM)7.76
FCFY5.07%
OCF(TTM)9.88
OCFY6.45%
SpS62.49
BVpS75.59
TBVpS-33.96
PEG (NY)1.43
PEG (5Y)5.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.79% | ||
| ROE | 6.02% | ||
| ROCE | 5.83% | ||
| ROIC | 5.16% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 25.37% | ||
| OM | 13.06% | ||
| PM (TTM) | 7.28% | ||
| GM | 44.64% | ||
| FCFM | 12.42% |
ROA(3y)2.96%
ROA(5y)2.8%
ROE(3y)6.26%
ROE(5y)6.09%
ROIC(3y)5.27%
ROIC(5y)4.6%
ROICexc(3y)5.45%
ROICexc(5y)4.78%
ROICexgc(3y)28.79%
ROICexgc(5y)25.46%
ROCE(3y)5.98%
ROCE(5y)5.22%
ROICexcg growth 3Y6%
ROICexcg growth 5Y0.79%
ROICexc growth 3Y6.82%
ROICexc growth 5Y5.36%
OM growth 3Y5.79%
OM growth 5Y2.6%
PM growth 3Y-6.88%
PM growth 5Y6.19%
GM growth 3Y0%
GM growth 5Y-1.08%
F-Score7
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 7.44 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 29.93% | ||
| Cap/Sales | 3.4% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 64.77% | ||
| Profit Quality | 170.57% | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 2.04 |
F-Score7
WACC7.12%
ROIC/WACC0.72
Cap/Depr(3y)37.86%
Cap/Depr(5y)40.69%
Cap/Sales(3y)4.42%
Cap/Sales(5y)4.86%
Profit Quality(3y)142.37%
Profit Quality(5y)192.14%
High Growth Momentum
Growth
EPS 1Y (TTM)15.21%
EPS 3Y0.23%
EPS 5Y2.41%
EPS Q2Q%5.68%
EPS Next Y8.85%
EPS Next 2Y6.03%
EPS Next 3Y6.35%
EPS Next 5Y6.08%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y1.79%
Revenue growth 5Y3.14%
Sales Q2Q%4.5%
Revenue Next Year8.24%
Revenue Next 2Y6.53%
Revenue Next 3Y5.94%
Revenue Next 5Y5.57%
EBIT growth 1Y-4.35%
EBIT growth 3Y7.69%
EBIT growth 5Y5.82%
EBIT Next Year33.02%
EBIT Next 3Y13.37%
EBIT Next 5Y13.84%
FCF growth 1Y126.68%
FCF growth 3Y-3.8%
FCF growth 5Y5.31%
OCF growth 1Y57.14%
OCF growth 3Y-6.5%
OCF growth 5Y2.66%